Zoetis Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other
companies in this sector in UNITED STATES :
Alexion Pharmaceuticals, Inc.
sales of $6.07 billion
of which 67%
Perrigo Company PLC
of which 53%
was CSCA), and
Vertex Pharmaceuticals Inc
of which 62%
During the second
quarter of 2021, sales at Zoetis Inc totalled
an increase of 25.8%
from the $1.55 billion in sales at the company during the second quarter of 2020.
This was the biggest same quarter rise in sales at Zoetis Inc in the previous 35 quarters.
During the first two
quarters of 2021, sales totalled $3.82 billion, which is
than through the first two quarters of 2020.
During the previous 22 quarters, sales at Zoetis Inc have increased compared with the same quarter in the previous year.
Sales at Zoetis Inc appear to have some seasonality: during each of the previous 9
years, sales have been highest during the fourth quarter, which has accounted for
between 26.1% and 27.6%
of the annual
During the year ended December of 2020, sales at
Zoetis Inc were $6.68 billion.
increase of 6.6%
versus 2019, when the company's sales were $6.26 billion.
This was the fifth consecutive year of sales increases at Zoetis Inc
(and since 2015, sales have increased a total of 40%).
Sales of International saw an increase
2.1% in 2020, from
$2.97 billion to $3.04 billion.
Not all segments of Zoetis Inc experienced an increase in sales in 2020:
sales of Contract Manufacturing fell 2.4% to $83.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).